Silence Therapeutics plc — Director's Dealing 2025

Jan 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Silence Therapeutics plc (SLN)
CIK: 0001479615
Period of Report: 2025-01-02

Reporting Person: Romano Steven J. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-02	Employee Share Option (Right to Buy)	$2.40	A	285000	Acquired	2035-01-02	Ordinary Shares (285000)	Direct

Footnotes

F1: One fourth (1/4th) of the shares subject to the option shall vest on January 2, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.